HSKA - Heska to Present at Upcoming Conferences in February and March 2021

PR Newswire

LOVELAND, Colo. , Feb. 16, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, announced that Kevin Wilson , Heska's President and Chief Executive Officer, will present at the following upcoming conferences in February and March 2021 :

• February 25, 2021 – Bank of America Securities 2021 Virtual Animal Health Summit . Mr. Wilson will present at 9:00 a.m. ET . The presentation webcast can be accessed at http://www.veracast.com/webcasts/bofa/animalhealth2021/idhK1lyO.cfm and the replay will be archived for 90 days following the event. Mr. Wilson and other members of Heska's management team will also participate in one-on-one meetings on February 25 .
• March 1, 2021 – Raymond James Virtual 42 ^nd Annual Institutional Investors Conference . Mr. Wilson will present at 3:50 p.m. ET . The presentation webcast can be accessed at https://kvgo.com/rjinstitutionalinvestors/heska-corporation-march-2021 and the replay will be archived for 90 days following the event. Mr. Wilson and other members of Heska's management team will also participate in one-on-one meetings on March 1 .
• March 9, 2021 – Barclays Global Healthcare Conference . Mr. Wilson will present at 4:10 p.m. ET . The presentation webcast can be accessed at https://kvgo.com/2021-global-healthcare-conference/heska-corp-march-2021 and the replay will be archived for 90 days following the event. Mr. Wilson and other members of Heska's management team will also participate in one-on-one meetings on March 9 .

For questions and more information, please contact Heska Investor Relations at investorrelations@heska.com .

About Heska
Heska Corporation (NASDAQ: HSKA) manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health.

SOURCE Heska Corporation